Drug Trial Radar · NCT00244842
Randomized Placebo-controlled Study of ISA247 in Plaque Psoriasis
Last checked: Nov 19, 2026Latest source record: Mar 27, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
451
Actual
Start
Dec 2004
Primary completion
Oct 2005
Study completion Oct 2005
Sponsor
- Lead sponsor
- Aurinia Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 27, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine which dose of voclosporin is effective in the treatment of plaque psoriasis compared to placebo.
Conditions
- Psoriasis
Interventions
voclosporinDrug
voclosporin 0.2, 0.3, or 0.4 mg/kg po BID
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Subjects Achieving a PASI-75 at 12 Weeks at Each of the 3 Dose Levels of Voclosporin.Time frame: Twelve Weeks
Locations
31 sites in 1 country. Site status is shown where the registry gives one.
Isotechnika Investigational Site
Calgary, Alberta, Canada
Isotechnika Investigational Site'
Edmonton, Alberta, Canada
Isotechnika Investigational Site
Edmonton, Alberta, Canada
Isotechnika Investigational Site
Vancouver, British Columbia, Canada
Isotechnika Investigational Site
Vancouver, British Columbia, Canada
Isotechnika Investigational Site
Victoria, British Columbia, Canada
Isotechnika Investigational Site
Winnipeg, Manitoba, Canada
Isotechnika Investigational Site
Moncton, New Brunswick, Canada
Isotechnika Investigational Site
St. John's, Newfoundland and Labrador, Canada
Isotechnika Investigational Site
St. John's, Newfoundland and Labrador, Canada
Isotechnika Investigational Site
Halifax, Nova Scotia, Canada
Isotechnika Investigational Site
Hamilton, Ontario, Canada
Isotechnika Investigational Site
London, Ontario, Canada
Isotechnika Investigational Site
London, Ontario, Canada
Isotechnika Investigational Site
Maple, Ontario, Canada
Isotechnika Investigational Site
Markham, Ontario, Canada
Isotechnika Investigational Site
Newmarket, Ontario, Canada
Isotechnika Investigational Site
North Bay, Ontario, Canada
Isotechnika Investigational Site
North Bay, Ontario, Canada
Isotechnika Investigational Site
Oakville, Ontario, Canada
Isotechnika Investigational Site
Oshawa, Ontario, Canada
Isotechnika Investigational Site
Toronto, Ontario, Canada
Isotechnika Investigational Site
Waterloo, Ontario, Canada
Isotechnika Investigational Site
Windsor, Ontario, Canada
Isotechnika Investigational Site
Windsor, Ontario, Canada
Isotechnika Investigational Site
Laval, Quebec, Canada
Isotechnika Investigational Site
Montreal, Quebec, Canada
Isotechnika Investigational Site
Montreal, Quebec, Canada
Isotechnika Investigational Site
Pointe-Claire, Quebec, Canada
Isotechnika Investigational Site
Sherbrooke, Quebec, Canada
Isotechnika Investigational Site
Ste. Foy, Quebec, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.